Poster Presentations Session II
Poster Presentations Session II Monday, May 21, 2018
POSTERS SET-UP: 3:15 PM - 3:30 PM
POSTERS DISPLAY HOURS: 3:30 PM - 7:30 PM
POSTER AUTHOR DISCUSSION: 6:30 PM - 7:30 PM
POSTERS DISMANTLE: 7:30 PM


Poster display locations are shown below the poster codes
HEALTH SERVICES - Clinical Outcomes Studies
PHS1
A1
WITHDRAWN

PHS2
A2
IMPACT OF PSYCHOSOCIAL FACTORS ON HEALTH SERVICES UTILIZATION AND COST OF CARE IN BLOOD AND MARROW TRANSPLANT PATIENTS
Koleva Y1, Abbrecht L2, Yeo J2, Zhang C3, Safah H2, Saba N2
1Tulane University Medical Center, New Orleans, LA, USA, 2Tulane University School of Medicine, New Orleans, LA, USA, 3Tulane University School of Public Health & Tropical Medicine, New Orleans, LA, USA

PHS3
A3
EVALUATING THE EFFECT OF THE CHANGE IN ACC/AHA BLOOD PRESSURE GUIDELINES ON THE PREVALENCE OF DIAGNOSED HYPERTENSION
Vasey J, Kallenbach L, Wilk A
Practice Fusion, San Francisco, CA, USA

PHS4
A4
EFFECT OF FASTING SERUM GLUCOSE CHANGE ON THE RISK OF CARDIOVASCULAR DISEASE IN MEN WITHOUT TYPE2 DIABETES
Kim SM1, Lee G2, Choi S1, Kim K1, Jeong S2, Son JS2, Yun J2, Park SM1
1Seoul National University, Seoul, Korea, Republic of (South), 2Seoul National University Hospital, Seoul, Korea, Republic of (South)

PHS5
A5
EXAMINATION OF OSTEOPOROSIS AND SUBSEQUENT FRACTURE RISK
Horváthné Kívés Z1, Kajári A2, Endrei D1, Boncz I1, Vajda R1
1University of Pécs, Pécs, Hungary, 2Tolna County Hospital, Szekszárd, Hungary

PHS6
A6
RACIAL/ETHNIC DIFFERENCES IN THE TREATMENT OF ADOLESCENT MAJOR DEPRESSIVE DISORDERS (MDD) ACROSS HEALTHCARE PROVIDERS PARTICIPATING IN THE MEDICAID PROGRAM
Yucel A1, Sanyal S2, Essien EJ2, Mgbere O2, Aparasu RR2, Bhatara V3, Alonzo J2, Chen H2
1Amgen, Thousand Oaks, CA, USA, 2University of Houston, Houston, TX, USA, 3University of South Dakota, Vermillion, SD, USA

PHS7
A7
HOSPITALISATION RATE AS A PROXY OUTCOME FOR CLINICAL VALUE IN A PROTOCOLISED CANCER TREATMENT ENVIRONMENT
Izzett M1, Kotze L1, Marais E2, Snyman J2
1Isimo Health, Bellville, South Africa, 2MSH, Bellville, South Africa

PHS8
A8
EFFECT OF PATIENT INVOLVEMENT AND MESSAGE FORMAT ON PERCEIVED SUSCEPTIBILITY AND SEVERITY TO BREAST CANCER
Bhansali AH1, Sansgiry SS2, Essien EJ3, Fleming ML2, Rajan S4, Mehta P3
1Philips, Pittsburgh, PA, USA, 2College of Pharmacy, University of Houston, Houston, TX, USA, 3University of Houston, Houston, TX, USA, 4University of Texas SPH, Houston, TX, USA

PHS9
A9
WITHDRAWN

PHS10
A10
PREVALENCE OF LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS IN COLOMBIA: A SINGLE SETTING STUDY
Santos-Moreno P1, Alvis-Zakzuk NJ2, Carrasquilla M3, Villarreal L4, Alvis Guzman N5
1Biomab, bogota, Colombia, 2Instituto Nacional de Salud, BOGOTA, Colombia, 3Alzak Foundation, Cartagena, Colombia, 4Biomab, center for rheumatoid arthritis, bogota, Colombia, 5ALZAK Foundation- Universidad De La Costa, Barranquilla, Colombia

PHS11
A11
WITHDRAWN

PHS12
A12
WITHDRAWN

PHS13
A13
WITHDRAWN

PHS14
A14
WITHDRAWN

HEALTH SERVICES - Cost Studies
PHS15
A15
THE IMPACT OF PATIENT-CENTERED MEDICAL HOME ON HYPERTENSION-ASSOCIATED HEALTH CARE UTILIZATION AND COST
Almalki ZS1, Alotaibi AA2, Bahowirth AM3, Alsalamah NM4, Alshahrani SM1
1PSAU, Al-Kharj, Saudi Arabia, 2Taif University, Taif, Saudi Arabia, 3Umm Alqura University, Mecca, Saudi Arabia, 4Qassim university, Buraydah, Saudi Arabia

PHS16
A16
THE ECONOMIC BURDEN OF OVERACTIVE BLADDER (OAB) IN BRAZIL: A RETROSPECTIVE OBSERVATIONAL STUDY USING DATA FROM THE SISTEMA UNICO DE SAUDE (SUS)
Lozano-Ortega G1, Ng DB2, Szabo SM1, Deighton A1, Gomes CM3, Guttschow A2, Gooch K4
1Broadstreet Health Economics & Outcomes Research, Vancouver, BC, Canada, 2Astellas Scientific and Medical Affairs, Inc, Northbrook, IL, USA, 3University of Sao Paulo, Sao Paulo, Brazil, 4Astellas Pharma Global Development, Inc., Northbrook, IL, USA

PHS17
A17
AN ECONOMIC EVALUATION OF CONSERVATIVE MANAGEMENT AND CRYOTHERAPY IN PATIENTS WITH LOCALIZED PROSTATE CANCER
Shah S1, Young HN2, Cobran EK2
1Evidera, Waltham, MA, USA, 2University of Georgia, Athens, GA, USA

PHS18
A18
LONG-TERM COSTS ASSOCIATED WITH ANTI-CYCLIC CITRULLINATED PEPTIDE POSITIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
An J1, Bider-Canfield Z2, Kang J1, Alemao E3, Connolly SE3, Lin AT4, Cheetham TC1
1Western University of Health Sciences, Pomona, CA, USA, 2Southern California Permanente Medical Group, Pasadena, CA, USA, 3Bristol-Myers Squibb, Princeton, NJ, USA, 4Southern California Permanente Medical Group, Fontana, CA, USA

PHS19
A19
REGULAR PHYSICAL ACTIVITY: IMPACT ON HEALTH CARE UTILIZATION PATTERNS AND EXPENSES IN A COHORT OF OVERWEIGHT AND OBESE US ADULTS WITH DIABETES
Wu J1, Davis-Ajami ML2, Lu KZ3
1Presbyterian College, Clinton, SC, USA, 2Indiana University, Bloomington, IN, USA, 3University of South Carolina, Columbia, SC, USA

PHS20
A20
COST OF CARE IN ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) IN THE IMMUNO-ONCOLOGY (IO) ERA: A REAL-WORLD ANALYSIS OF EARLY DATA
Radtchenko J1, Korytowsky B2, Nwokeji E2, Tuell K2, Feinberg B1
1Cardinal Health, Dublin, OH, USA, 2Bristol-Myers Squibb, Princeton, NJ, USA

PHS21
A21
UTILIZATION OF A PRECISE, CLINICALLY RELEVANT, DIGITAL CLASSIFICATION SYSTEM TO IDENTIFY VARIATION IN CARE AND COSTS AMONG PATIENTS WITH BREAST CANCER
Collins A, Natale M, Castaneda E, Noh Hg, Arunajadai S, Patel J, Ng K, Mathura S, Cady S, West D, Paddock S, Norden AD
Cota Inc, New York, NY, USA

PHS22
A22
ANALYTIC MODEL TO ESTIMATE COSTS OF TWO DIALYSIS MODALITIES IN PARAGUAY
Ayala R1, Ariza JG2, Morinigo K3, Caceres P4
1Instituto de Previsión Social, Asunción, Paraguay, 2BAXTER, BOGOTA, Colombia, 3IPS Hospital Central Paraguay, Asunción, Paraguay, 4Santorio AMSA Paraguay, Asunción, Paraguay

PHS23
A23
UNDERSTANDING HEART FAILURE BURDEN IN MIDDLE EAST COUNTRIES: ECONOMIC IMPACT IN EGYPT, SAUDI ARABIA AND UNITED ARAB EMIRATES
AlHabeeb W1, Akhras K2, AlGhalayini K3, Al-Mudaiheem H4, Ibrahim B5, Lawand S6, Al-Ayoubi F7, ElSalah R8, Shaikh A9, Bader F10
1Kind Saud University, Riyadh, Saudi Arabia, 2Novartis AG, Dubai, United Arab Emirates, 3King Abdul-Aziz University Hospital, Jeddah, Saudi Arabia, 4Ministry of Health, Riyadh, Saudi Arabia, 5North Cumbria Universty Hospitals, Carlisle, UK, 6Dallah Hospital, Riyadh, Saudi Arabia, 7King Saud University, Riyadh, Saudi Arabia, 8Novartis Pharma Services, Dubai, United Arab Emirates, 9Ernst & Young (Dubai Branch), Dubai, United Arab Emirates, 10Cleveland Clinic Abu Dhabi., Abu Dhabi, United Arab Emirates

PHS24
A24
HEALTH CARE COSTS AND UTILIZATION ASSOCIATED WITH HIGH RISK PRESCRIPTION OPIOID USE
Chang H1, Kharrazi H1, Bodycombe D1, Weiner JP1, Alexander GC2
1Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, Baltimore, MD, USA, 2Johns Hopkins Bloomberg School of Public Health, Center for Drug Safety and Effectiveness, Baltimore, MD, USA

PHS25
A25
WITHDRAWN

PHS26
A26
HEALTH CARE RESOURCE UTILIZATION (HCRU) OF HEAD AND NECK CANCERS (HNC) IN HUNGARY: A RETROSPECTIVE CROSS-SECTIONAL ANALYSIS OF THE NATIONAL HEALTHCARE SERVICES CENTER DATABASE IN 2010-2016
Szűcs A1, Kováts T2, Brandtmüller Á3, Chirovsky D4, Nagy B5, Voko Z6
1Eotvos Lorand University, Budapest, Hungary, 2National Healthcare Services Center, Budapest, Hungary, 3MSD Pharma Hungary Ltd, Budapest, Hungary, 4Merck and Co. Inc., Kenilworth, NJ, USA, 5Eötvös Loránd University (ELTE), Budapest, Hungary, 6Eötvös Loránd University, Budapest, Hungary

PHS27
A27
ASSOCIATION OF THE HOSPITAL COST FOR COPD WITH GDP PER CAPITA: EVIDENCE FOR BRAZILIAN STATES, 2000-2014
Pinto CR1, Lemos AC2, Assunção-Costa LA2, Yamamura LL2, Alcântara AT2, Valli CG2, Almeida AT3
1Southwest Bahia State University, Jequié, Brazil, 2Federal University of Bahia, Salvador, Brazil, 3Federal University of Paraiba, João Pessoa, Brazil

PHS28
A28
COSTS RELATED TO INFUSION THERAPY ROOM AND STAFF FOR RHEUMATOID ARTHRITIS IN A SPECIALIZED CENTER
Santos-Moreno P1, Buitrago-Garcia D2, Villarreal L3, Alvis-Zakzuk N4, Carrasquilla M4, Alvis Guzman N5
1Biomab, bogota, Colombia, 2SIIES investigation and research, Colombia, bogota, Colombia, 3Biomab, center for rheumatoid arthritis, bogota, Colombia, 4Alzak Foundation, Cartagena, Colombia, 5ALZAK Foundation- Universidad De La Costa, Barranquilla, Colombia

PHS29
A29
GEOGRAPHIC VARIATION IN OPIOID RELATED OUTPATIENT HEALTHCARE UTILIZATION IN THE UNITED STATES: A RETROSPECTIVE STUDY OF A LARGE HEALTH SYSTEM’S CLAIMS DATA
Mallow P1, Belk K2, Craver C2
1Xavier University, Cincinnati, OH, USA, 2Vizient Inc., Mooresville, NC, USA

PHS30
A30
GEOGRAPHIC VARIATION IN OPIOID RELATED INPATIENT HEALTHCARE UTILIZATION IN THE UNITED STATES: A RETROSPECTIVE STUDY OF A LARGE HEALTH SYSTEM’S CLAIMS DATA
Mallow P1, Belk K2, Craver C2
1Xavier University, Cincinnati, OH, USA, 2Vizient Inc., Mooresville, NC, USA

PHS31
A31
HEALTHCARE RESOURCE UTILISATION AND COSTS OF AGITATION IN PEOPLE WITH DEMETIA LIVING IN CARE HOMES - THE MANAGING AGITATION AND RAISING QUALITY OF LIFE IN DEMENTIA (MARQUE) STUDY
Panca M, Livingston G, Barber J, Cooper C, La Frenais F, Marston L, Hunter RM
University College London, London, UK

PHS32
A32
INCREMENTAL HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES FROM SOLID TUMORS
Bhowmik D1, Hines DM2, Karkare S3, Intorcia M4, Wade RL2
1Amgen Inc., Thousand Oaks, CA, USA, 2IQVIA, Plymouth Meeting, PA, USA, 3IQVIA, Deerfield, IL, USA, 4Amgen GmbH, Zug, Switzerland

PHS33
A33
HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG COMMERCIALLY INSURED PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN THE UNITED STATES
Bonafede MM1, McMorrow D1, Marshall A2, Gupta K2, Pazirandeh M2
1Truven Health Analytics, an IBM Company, Cambridge, MA, USA, 2Bristol Myers Squibb, Lawrence Township, NJ, USA

PHS34
A34
WITHDRAWN

PHS35
A35
WITHDRAWN

PHS36
A36
WITHDRAWN

PHS37
A37
ANALYSIS OF COST FOR ART CYCLES IN UKRAINE
Stasiv K, Zaliska O, Maksymovych N
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

PHS38
A38
WHAT IS THE COST OF A BREAST CANCER THERAPY INFUSION? REAL WORLD DATA ON BRAZILIAN PRIVATE HEALTHCARE PERSPECTIVE
Julian GS1, Martins RE2
1Evidências - Kantar Health, São Paulo, Brazil, 2Evidências - Kantar Health / Clínica UNICA, São Paulo, Brazil

PHS39
A39
AN ANALYSIS OF HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH PATIENTS WITH ACUTE HEPATIC PORPHYRIAS (AHPS) WITH RECURRENT ATTACKS IN EXPLORE: A PROSPECTIVE, MULTINATIONAL NATURAL HISTORY STUDY OF PATIENTS WITH AHP
Gouya L1, Bloomer JR2, Balwani M3, Bissell DM4, Rees DC5, Stölzel U6, Phillips JD7, Kauppinen R8, Langendonk JG9, Desnick R3, Deybach J1, Bonkovsky HL10, Parker C7, Naik H3, Badminton M11, Stein P5, Minder EI12, Windyga J13, Martasek P14, Cappellini M15, Ventura P16, Sardh E17, Harper P17, Sandberg S18, Aarsand A18, Alegre F19, Ivanova A20, Talbi N1, Chan A21, Querbes W21, Penz C21, Agarwal S21, Simon A21, Anderson KE22
1Centre Français des Porphyries, Colombes, France, 2University of Alabama, Birmingham, Birmingham, AL, USA, 3Mt. Sinai Icahn School of Medicine, New York City, NY, USA, 4University of California, San Francisco, San Francisco, CA, USA, 5King’s College Hospital, London, UK, 6Klinikum Chemnitz, Chemnitz, Germany, 7University of Utah, Salt Lake City, UT, USA, 8University Hospital of Helsinki, Helsinki, Finland, 9Erasmus Medical Center, Rotterdam, The Netherlands, 10Wake Forest University, Winston-Salem, NC, USA, 11University Hospital of Wales, Cardiff, UK, 12Stadtspital Triemli, Zentrallabor, Zurich, Switzerland, 13Instytut Hematologii i Transfuzjologii, Warsaw, Poland, 14Univerzity Karlovy v Praze, Prague, Czech Republic, 15University of Milan, Milan, Italy, 16Università degli Studi di Modena e Reggio Emilia, Modena, Italy, 17Karolinska University Hospital, Solna, Sweden, 18Norwegian Porphyria Centre, Bergen, Norway, 19Clinica Universidad de Navarra, Navarra, Spain, 20St. Ivan Rilski University Hospital, Sofia, Bulgaria, 21Alnylam Pharmaceuticals, Cambridge, MA, USA, 22University of Texas Medical Branch, Galveston, Galveston, TX, USA

PHS40
A40
COST-EFFECTIVENESS OF THERAPEUTIC DRUG MONITORING FOR IMATINIB ADMINISTRATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
Kim K, Walker B, McMillin GA, Bernard PS, Schmidt RL
University of Utah, Salt Lake city, UT, USA

PHS41
A41
ESTIMATING THE COST AND COST-EFFECTIVENESS FOR OBSTETRIC FISTULA REPAIR IN LOW-INCOME COUNTRIES
Epiu I1, Alia G2, Mukisa J3, Tavrow P4, Lamorde M5, Kuznik A6
1University of California Global Health Institute, Nairobi, Kenya, 2Mulago National Referral Hospital, Kampala, Uganda, 3Makerere University College of Health Sciences, Kampala, Uganda, 4Bixby Program in Population and Reproductive Health, University of California at Los Angeles,, LA, CA, USA, 5Infectious Diseases Institute, Makerere University, Kampala, Uganda, 6Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

PHS42
WITHDRAWN

PHS43
A42
TRENDS IN REGIONAL VARIATION AMONG INPATIENTS WITH BREAST CANCER IN THE UNITED STATES: ANALYSIS OF 2010-2014 HEALTHCARE COST AND UTILIZATION PROJECT DATA
Dhumal T, Mehta Z, Kamal KM
Duquesne University School of Pharmacy, Pittsburgh, PA, USA

PHS44
A43
RESOURCE USE OF PATIENTS DIAGNOSED WITH SCHIZOPHRENIA: ANALYSIS OF PHYSICIAN RECORD FORM DATA IN THE UNITED STATES
Gavaghan M1, Hertz D1, Howe T2
1GfK, Waltham, MA, USA, 2GfK UK, London, UK

HEALTH SERVICES - Patient-Reported Outcomes & Patient Preference Studies
PHS45
A44
WITHDRAWN

PHS46
A45
WITHDRAWN

PHS47
A46
A CROSS SECTIONAL STUDY OF THE FACTORS THAT AFFECT THERAPY ADHERENCE IN CHILDREN WITH ATTENTION DEFICIT DISORDER/ ATTENTION DEFICIT/HYPERACTIVITY DISORDER
Saeed NS1, Cleary SD2, Maneno M1
1Howard University, Washington, DC, USA, 2George Washington University, Washington, DC, USA

PHS48
A47
BASELINE HEALTH UTILITY SCORES IN SUBJECTS WITH SUSPECTED OCULAR DISEASE: AN INTERIM ANALYSIS OF THE PHILADELPHIA TELEMEDICINE GLAUCOMA DETECTION AND FOLLOW-UP STUDY
Mehta R1, Prioli KM1, Hark L2, Katz LJ3, Myers JS3, Pizzi LT1
1Rutgers University, Piscataway, NJ, USA, 2Columbia University Medical Center, New York, NY, USA, 3Wills Eye Hospital, Philadelphia, PA, USA

PHS49
A48
HEALTH UTILITY OF HOSPITALIZED STROKE PATIENTS IN VIETNAM, COMPARING EARLY STAGE TO DISCHARGE
Hoang NB1, Postma MJ2, Nguyen TP1
1Thai Nguyen University of Medicine and Pharmacy, Thai Nguyen, Viet Nam, 2Unit of PharmacoTherapy, ­Epidemiology & ­Economics (PTE2), University of Groningen, Department of Pharmacy, Groningen, The Netherlands

PHS50
A49
DEVELOPMENT OF PATIENT-REPORTED OUTCOME MEASURES FOR MASSETER PROMINENCE
Fabi S1, Narurkar V2, Donofrio L3, Banderas B4, Garcia J5
1Cosmetic Laser Dermatology, San Diego, CA, USA, 2Bay Area Laser Institute, San Francisco, CA, USA, 3Donofrio Dermatology PC, Madison, CT, USA, 4Adelphi Values, Boston, MA, USA, 5Allergan plc, Irvine, CA, USA

PHS51
A50
HETEROGENEITY IN PREFERENCES FOR MEDICAL MALE CIRCUMCISION SERVICES: A DISCRETE CHOICE EXPERIMENT AMONG UNCIRCUMCISED MEN IN FISHING COMMUNITIES IN UGANDA
Lubinga SJ1, Babigumira JB1, Graham SM1, Mukose A2, Garrison L1, Basu A1
1University of Washington, Seattle, WA, USA, 2Makerere University, Kampala, Uganda

PHS52
B1
TREATMENT OUTCOME PRIORITIES FOR YOUTH WITH MULTI-MORBID MENTAL HEALTH CONDITIONS: A LATENT CLASS ANALYSIS OF A BEST-WORST SCALING EXPERIMENT
dosReis S1, Camelo Castillo W1, Ross M1, N'Dri L1, Butler B2
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2SWATS, LLC, Manchester, MD, USA

PHS53
B2
PERCEIVED CANCER RISK AND EVALUATION OF PUBLIC AWARENESS OF DIRECT-TO-CONSUMER GENETIC TESTS IN THE UNITED STATES
Wei H1, Chen Z2, Cobran EK1
1University of Georgia, Athens, GA, USA, 2University of Georiga, athens, GA, USA

PHS54
B3
DIABETES MEDICATION ADHERENCE AND CHANGES IN HEALTHCARE RESOURCE USE OVER TIME
Carpinella CM1, Calhoun S2, Way N1, Doane MJ2
1Kantar Health, San Mateo, CA, USA, 2Kantar Health, Horsham, PA, USA

PHS55
B4
QUANTITATIVE ASSAY OF FECAL CALPROTECTIN IN CHILDREN WITH COW’S MILK PROTEIN ALLERGY
Lendvai-Emmert D1, Emmert V2, Fusz K1, Prémusz V1, Boncz I1, Tóth GP2
1University of Pécs, Pécs, Hungary, 2Erzsébet Teaching Hospital and Rehabilitation Institute, Sopron, Sopron, Hungary

PHS56
B5
THE PATIENT EXPERIENCE AND BUPRENORPHINE USE AMONG PREGNANT AND POSTPARTUM WOMEN
Titus-Glover D1, Shaya FT2
1University of Maryland, Baltimore, MD, USA, 2University of Maryland School of Pharmacy, Baltimore, MD, USA

PHS57
B6
FINANCIAL IMPACT AND EXPERIENCE WITH GENERAL MEDICAL SERVICES AMONG CANCER SURVIVORS IN THE UNITED STATES
Wei H, Zhuo C, Cobran EK
University of Georgia, Athens, GA, USA

PHS58
B7
ASSESSING SYMPTOM CHANGE AT THE INDIVIDUAL LEVEL USING ITEM RESPONSE THEORY VERSUS SUM SCORING: IMPLICATIONS FOR DEPRESSION TREATMENT
Jones SM1, Crane P2, Simon G3
1Fred Hutchinson Cancer Research Center, Seattle, WA, USA, 2University of Washington, Seattle, WA, USA, 3Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA

PHS59
B8
WITHDRAWN

PHS60
B9
WITHDRAWN

HEALTH SERVICES - Health Care Use & Policy Studies
PHS61
B10
IDENTIFYING COMMUNITY-REPORTED HEALTH PRIORITIES USING FREE LISTING INTERVIEWS IN A MIXED METHODS APPROACH
Decker-Palmer M1, Thompson T1, George M1, Frasso R2
1Thomas Jefferson University, Johnstown, PA, USA, 2Thomas Jefferson University, Philadelphia, PA, USA

PHS62
B11
BRIDGING THE CONSUMERIZATION OF HEALTHCARE INTO THE LABORATORY TEST SETTING
Vazquez VC, Girardi M
GfK, Waltham, MA, USA

PHS63
B12
WITHDRAWN

PHS64
B13
WITHDRAWN

PHS65
B14
EXPERIENCES OF HEALTH AND SOCIAL INEQUALITIES IN AFRICAN ASYLUM SEEKERS AND REFUGEES IN MANCHESTER, UK: A THEMATIC ANALYSIS
Fatoye C1, Fatoye F2
1HEMAC, MANCHESTER, UK, 2Manchester Metropolitan University, Manchester, UK

PHS66
B15
COST AND EFFECTIVENNES OF A SCREENING ALGORITHM FOR THE DIAGNOSIS OF RHEUMATOID ARTHIRITS
Santos-Moreno P1, Buitrago-Garcia D2, Villarreal L3, Alvis-Zakzuk N4, Carrasquilla M4, Alvis Guzman N5
1Biomab, bogota, Colombia, 2SIIES investigation and research, Colombia, bogota, Colombia, 3Biomab, center for rheumatoid arthritis, bogota, Colombia, 4Alzak Foundation, Cartagena, Colombia, 5ALZAK Foundation- Universidad De La Costa, Barranquilla, Colombia

PHS67
B16
THE ZERO DOLLAR COPAY DISEASE MANAGEMENT PROGRAM: LOWERING HEALTHCARE UTILIZATION IN PATIENTS WITH CHRONIC DISEASES
Yuan X, Zhang Y, Ouyang J, Chaisson J, Louis K, Mohundro B, Cantrell D, Neely C, Washington V, Nigam S
Blue Cross Blue Shield of Louisiana, Baton Rouge, LA, USA

PHS68
B17
A STUDY OF PERIPHERAL LOWER-EXTREMITY DISEASES-RELATED HOSPITALIZATION DISCHARGE STATUS AND ITS ASSOCIATION WITH DIABETES USING A US NATIONAL DATABASE
Zhao R1, Carlson AM2
1University of Minnesota, Minneapolis, MN, USA, 2Data Intelligence Consultants, LLC, Eden Prairie, MN, USA

PHS69
B18
A CASE MANAGEMENT APPROACH TO REDUCING ER VISITS: A BLUE CROSS BLUE SHIELD OF LOUISIANA (BCBLSA) CASE STUDY
Liu M, Guh S, Chaisson J, Tisdale K, Nigam S
Blue Cross Blue Shield of Louisiana, Baton Rouge, LA, USA

PHS70
B19
FACTORS ASSOCIATED WITH NON-PERSISTENT SURVEILLANCE AFTER DIAGNOSIS OF ORAL POTENTIALLY MALIGNANT DISORDERS
Cheng J, Ku H
Chang Gung University, Tao-Yuan, Taiwan

PHS71
B20
APPLYING POPULATION HEALTH MANAGEMENT TECHNIQUES TO LOWER HEALTHCARE UTILIZATION IN PATIENTS WITH NON-CHRONIC COMPLEX DISEASES
Yuan X, Zhang Y, Ouyang J, Chaisson J, Tisdale K, Bergeron T, Cantrell D, Washington V, Nigam S
Blue Cross Blue Shield of Louisiana, Baton Rouge, LA, USA

PHS72
B21
THE ZERO DOLLAR COPAY DISEASE MANAGEMENT PROGRAM: LOWERING HEALTHCARE UTILIZATION IN PATIENTS WITH DIABETES
Yuan X, Zhang Y, Ouyang J, Chaisson J, Louis K, Mohundro B, Cantrell D, Neely C, Washington V, Nigam S
Blue Cross Blue Shield of Louisiana, Baton Rouge, LA, USA

PHS73
B22
OPIOID ANALGESIC PRESCRIBING RELATED TO DENTAL VISITS IN THE MISSISSIPPI MEDICAID POPULATION
Dibie C1, Ward L2, Banahan III B1, Yang Y2, Noble S3
1Center for Pharmaceutical Marketing and Management, University of Mississippi, University, MS, USA, 2University of Mississippi, University, MS, USA, 3Office of the Governor, Mississippi Division of Medicaid, Jackson, MS, USA

PHS74
WITHDRAWN

PHS75
B23
A WORK-SAMPLING STUDY OF AN INNOVATIVE PEDIATRIC CARE-COORDINATION PROGRAM FOR ASTHMA, DIABETES, AND SICKLE CELL PATIENTS
Talon B1, Gerges M2, Perry-Bell K2, Caskey R2, Van Voorhees B2, Touchette DR1
1University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA, 2University of Illinois at Chicago Department of Pediatrics, Chicago, IL, USA

PHS76
B24
THE EFFECT OF PATIENT-CENTERED ONCOLOGY CARE ON HEALTHCARE UTILIZATION AND COST: A SYSTEMATIC REVIEW AND META-ANALYSIS
Hailun L1, Beydoun MA2, Eid SM3, Tao L1
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, 2National Institute on Aging, Baltimore, MD, USA, 3Johns Hopkins University School of Medicine, Baltimore, MD, USA

PHS77
B25
MAPPING THE GAPS: GENDER DIFFERENCES IN PREVENTIVE CARDIOVASCULAR CARE AMONG MANAGED CARE MEMBERS IN FOUR METROPOLITAN AREAS
Bird C1, Manocchia M2, Tomblin B3, Payne P3, Kulakodlu M4, Fremont A5
1RAND Corporation, Santa Monica, CA, USA, 2University of North Florida, Jacksonville, NC, USA, 3Cigna, Irvine, CA, USA, 4Cigna, Raleigh, NC, USA, 5RAND Corporation, Santa Monica, NC, USA

PHS78
B26
THE COST EFFECTIVENESS OF A PATIENT EDUCATION MOBILE PLATFORM IN PREVENTING MOTHER TO INFANT TRANSMISSION OF HEPATITIS B IN THE CHINESE POPULATION
Xuan D1, Cao X2, Hou J3
1University of North Carolina Gillings Global School of Public Health, Chapel Hill, NC, USA, 2Hangzhou Tigermed Consulting Co., Ltd, Hangzhou, China, 3Nanfang Medical University, Guangzhou, China

PHS79
B27
RELATIVE CLINICAL AND ECONOMIC BURDEN OF COMMUNITY ACQUIRED PNEUMONIA IN THE ELDERLY
Olasupo OO1, Brown J2
1University of Florida, GAINESVILLE, FL, USA, 2University of Florida, Gainesville, FL, USA

PHS80
B28
CONTRASTING UTILIZATION OF INPATIENT HOSPITALIZATIONS AND EMERGENCY DEPARTMENT VISITS BETWEEN MEDICAID AND COMMERCIALLY INSURED ARKANSANS
Bhandari NR1, Chopra DA1, Kathe N1, Moore G1, Lewis K2, Li C1, Goudie A3, Martin BC1
1University of Arkansas for Medical Sciences, Little Rock, AR, USA, 2Arkansas Center for Health Improvement, Little Rock, AR, USA, 3Arkansas Children's Hospital, Little Rock, AR, USA

PHS81
B29
IMPACT OF THE AFFORDABLE CARE ACT (ACA)’S ELIMINATION OF COST-SHARING PROVISION ON THE GUIDELINE-RECOMMENDED CANCER PREVENTIVE SCREENINGS IN THE UNITED STATES
Bhandari NR, Li C
University of Arkansas for Medical Sciences, Little Rock, AR, USA

PHS82
B30
RAPID DISSEMINATION OF H. PYLORI ERADICATION FOR CHRONIC GASTRITIS AMONG ASYMPTOMATIC PEOPLE
Hamashima C1, Narisawa R2
1Teikyo University, Tokyo, Japan, 2Niigata Cancer Center Hospital, Niigata, Japan

PHS83
B31
COMPARATIVE EFFECTIVENESS OF MTM ELIGIBILITY CRITERIA UNDER ACA AND MMA ACROSS RACIAL AND ETHNIC GROUPS IN MEDICARE
Wang J1, Qiao Y1, Spivey C1, Shih YT2, Wan J3, Kuhle J4, Dagogo-Jack S3, Cushman W3, Chisholm-Burns M1
1The University of Tennessee Health Science Center College of Pharmacy, Memphis, TN, USA, 2The University of Texas MD Anderson Cancer Center, Houston, TX, USA, 3The University of Tennessee Health Science Center College of Medicine, Memphis, TN, USA, 4Pharmacy Quality Alliance, Springfield, VA, USA

PHS84
B32
RACIAL DISPARITY IN THE USE OF FIRST-LINE PSYCHOSOCIAL CARE FOR CHILDREN AND ADOLESCENTS INITIATING THERAPY ON ANTIPSYCHOTICS
Salkar M1, Banahan III B1, Noble S2
1Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS, USA, 2Mississippi Division of Medicaid, Jackson, MS, USA

PHS85
B33
EXAMINING THE EFFECT OF MISSING DATA ON THE ACMG NEWBORN SCREENING CRITERIA OF LEAST CONSENSUS FOR CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY (CPTII)
Redlich A, Rittenhouse B
MCPHS University, Boston, MA, USA

PHS86
B34
ACCESS TO PATIENT-CENTERED MEDICAL HOME CARE AMONG ADULTS WITH CHRONIC CONDITIONS: FINDINGS FROM THE MEDICAL EXPENDITURES PANEL SURVEY
Almalki ZS1, Karami N2, Almasoudi I2, ALHasoun R3, Alabsi E4, Mahdi AT2
1PSAU, Al-Kharj, Saudi Arabia, 2Umm Al-Qura University, Mecca, Saudi Arabia, 3Princess Nora bint abdulrahman University, Riyadh, Saudi Arabia, 4Jazan university, Jazan, Saudi Arabia

PHS87
B35
A REVIEW OF FACTORS ASSOCIATED WITH ACCESS TO CARE IN BREAST CANCER PATIENTS
Brown CM1, Richards K2, Kanu CN2, Sasane R3, Tang DH3, Stevens L4
1The University of Texas at Austin, Austin, LA, USA, 2The University of Texas at Austin, Austin, TX, USA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 4Innovative Oncology Business Solutions, Albuquerque, NM, USA

PHS88
B36
DETERMINANTS AND IMPACT OF CONTINUITY OF CARE IN INDIVIDUALS NEWLY DIAGNOSED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Cheng J, Ku H
Chang Gung University, Tao-Yuan, Taiwan

PHS89
B37
WITHDRAWN

PHS90
B38
WITHDRAWN

PHS91
B39
DO MEDICAL HOMES AFFECT HEALTHCARE UTILIZATION RATES? A LONGITUDINAL EVALUATION ON MEDICAL HOME IMPLEMENTATION IN ITALY
Voelker J1, Hegarty SE2, Keith SW2, Alcusky M3, Lombardi M4, Maio V2
1Jefferson College of Population Health at Thomas Jefferson University, Philadelphia, PA, USA, 2Thomas Jefferson University, Philadelphia, PA, USA, 3University of Massachusetts Medical School, Worcester, MA, USA, 4Parma Local Health Authority, Parma, Italy

PHS92
B40
WITHDRAWN

PHS93
B41
ARMED CONFLICT AND INFANT MORTALITY DUE TO DIARRHEA IN COLOMBIAN CHILDREN
Alvis-Zakzuk NJ1, Diaz-Jimenez D2, Valencia S2, Gutierrez-Clavijo J2, Cotes K2, Castañeda-Orjuela C3, Alvis Guzman N4, De la Hoz Restrepo F5
1ALZAK Group, Cartagena, Colombia, 2Instituto Nacional de Salud, Bogotá, Colombia, 3Instituto Nacional de Salud, Bogotá, D.C., Colombia, 4Universidad de Cartagena - ALZAK Foundation, Cartagena, Colombia, 5Universidad Nacional de Colombia, Bogotá, D.C., Colombia

PHS94
B42
DIFFERENCES IN HPV VACCINE UPTAKE BY NATIVITY STATUS AMONG AMERICAN MEN AGED 18-32
Adjei Boakye E1, Zeng W2, Anderson L2, Chen J1, Tobo BB2, Osazuwa-Peters N3
1Saint Louis University Center for Outcomes Research, Saint Louis, MO, USA, 2Saint Louis University, Saint Louis, MO, USA, 3Saint Louis University Cancer Center, Saint Louis, MO, USA

PHS95
B43
RACIAL/ETHNIC DISPARITY IN HRQOL: IMPLICATIONS OF SOCIAL SUPPORT AND SOCIAL CONNECTEDNESS IN THYROID CANCER CARE.
Wirth LS
Saint Louis University Center for Health Outcomes Research (SLUCOR), Saint Louis, MO, USA

PHS96
B44
INFANT MORTALITY FROM ACUTE RESPIRATORY INFECTIONS AND ARMED CONFLICT: AN EXPLORATORY ANALYSIS
Alvis-Zakzuk NJ1, Diaz-Jimenez D2, Valencia S2, Gutierrez-Clavijo J2, Cotes K2, Castañeda-Orjuela C3, Alvis Guzman N4, De la Hoz Restrepo F5
1Instituto Nacional de Salud, BOGOTA, Colombia, 2Instituto Nacional de Salud, Bogotá, Colombia, 3Instituto Nacional de Salud, Bogotá, D.C., Colombia, 4ALZAK Foundation- Universidad De La Costa, Barranquilla, Colombia, 5Universidad Nacional de Colombia, Bogotá, D.C., Colombia

PHS97
B45
ANALYSIS OF PERFORMANCE TO MAXIMISE EFFECTIVENESS OF RESOURCE ALLOCATION IN AN INTEGRATED CARE TEAM PLAN
Orlowski A1, Belsey J2, Ashton R1
1Imperial College Health Partners, London, UK, 2JB Medical Ltd, Sudbury, UK

PHS98
B46
COST ESTIMATION OF PHARMACY SERVICES AND THE RECOMMENDATION OF NEW CHARGE ITEMS IN HOSPITALS OF SOUTHWEST CHINA
Guo X1, Xiong H1, Liu H1, Wu X2, Xiong X1, Zhang J1, Long E3
1Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China, 2Sichuan University, Chengdu, China, 3Personalized drug therapy key Laboratory of Sichuan Province, Chengdu, China

PHS99
C1
ECONOMIC BURDEN OF NON–COMMUNICABLE DISEASES (NCDS) IN POLAND
Leśniowska J
Kozminski University, Warsaw, Poland

PHS100
C2
HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH ANGELMAN SYNDROME STRATIFIED BY AGE
Cabo R
Ovid Therapeutics, New York, NY, USA

PHS101
C3
COST ANALYSIS OF MEDICATION THERAPY MANAGEMENT - USING PROPENSITY SCORE MATCHING METHOD
Huang C, Chen D, Jaynes HA, Sabbaghi A, Zillich AJ
Purdue University, West Lafayette, IN, USA

PHS102
C4
AN ANALYSIS OF OUTPATIENT HEALTHCARE UTILIZATION AND COSTS IN CHILDREN WITH SEVERE MUCOPOLYSACCHARIDOSIS TYPE I IN THE UNITED STATES
Conner TM1, Cook FM1, Cho Y1, Fernandez V1, Rascati KL2
1REGENXBIO, Rockville, MD, USA, 2The University of Texas at Austin, Austin, TX, USA

PHS103
C5
MEDICAL EXPENDITURES FOR PATIENTS WITH PULMONARY EMBOLISM AMONG THE POPULATION WITH URBAN BASIC HEALTH INSURANCE IN CHINA
Wang J1, Yang L1, Wu J2, He L1
1Peking University, Beijing, China, 2Bayer Healthcare Company Ltd, Beijing, China

PHS104
C6
MEASURING THE EXTENT AND IMPACT OF DISEASE SUB-SPECIALIZATION AMONG NEUROLOGISTS IN THE US
Miyasato G1, Nerurkar J2, Clare B2, Jiang S2, Clapham C2, Wang T2, Tao R2, Yajima M2
1Trinity Partners, LLC, Waltham, MA, USA, 2Boston University, Boston, MA, USA

PHS105
C7
EMERGENCY ROOM VISITS AND OUT OF POCKET EXPENDITURE AMONG INDIVIDUALS ENROLLED IN A HIGH DEDUCTIBLE HEALTH PLAN
Mahashabde R, Vaidya V
University of Toledo, Toledo, OH, USA

PHS106
C8
HEALTHCARE RESOURCES PATTERNS AND COST ANALYSIS OF PULMONARY ARTERIAL HYPERTENSION IN A TERTIARY CARE SETTING IN MEXICO CITY
Cerezo O1, Guillen-López C2, Rangel-Frausto S3, Arana JC3, Anaya P4
1NIH-Respiratory Diseases, Mexico City, Mexico, 2NIH Respiratory DIseases, Mexico City, Mexico, 3Glaxo SmithKline Mexico, Mexico City, Mexico, 4IQVIA, México, D.F., Mexico

PHS107
C9
WITHDRAWN

PHS108
C10
WITHDRAWN

PHS109
C11
PHARMACOECONOMICS IN NEPAL: NEED FOR A PARADIGM SHIFT
Paudel P
Pukyong National University, BUSAN, Korea, Republic of (South)

PHS110
C12
ONE DECADE COST OF CANCER TREATMENT IN BRAZIL AND ITS DETERMINANTS
Cherchiglia ML1, Lana AP1, Perelman J2, Andrade EI1, Guerra-Junior Aa3, Acurcio FA1, Ferre F1
1Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 2Escola Nacional de Saúde Pública. Universidade NOVA de Lisboa, Lisbon, Portugal, 3SUS Collaborating Centre - CCATES - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

PHS111
WITHDRAWN

PHS112
C13
EMERGENCY DEPARTMENT (ED) UTILIZATION FOR DENTAL OR ORAL HEALTH RELATED CONDITIONS (DOHRC) BEFORE AND AFTER IMPLEMENTATION OF AFFORDABLE CARE ACT (ACA)
Shah SS, Slejko J, Villalonga Olives E, Shaya F
University of Maryland Baltimore, Baltimore, MD, USA

PHS113
C14
GEOGRAPHIC VARIATION IN UTILIZATION OF PHYSICIAN SERVICES AMONG OLDER ADULTS DIAGNOSED WITH NON-HODGKIN LYMPHOMA
Onukwugha E1, Jayasekera J2, Gandhi AB1, Vapiwala N3, Mair C4, Lehning A5, Yared JA6
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2Georgetown University Medical Center, Washington, DC, USA, 3University of Pennsylvania School of Medicine, Philadelphia, PA, USA, 4University of Maryland Baltimore County, Baltimore, MD, USA, 5University of Maryland School of Social Work, Baltimore, MD, USA, 6University of Maryland, Greenebaum Cancer Center, Baltimore, MD, USA

PHS114
C15
FACTORS ASSOCIATED WITH BREAST CANCER SCREENING AMONG AFRICAN AMERICAN WOMEN
Orji CC1, Kanu CN1, Adelodun AI2, Brown CM1
1The University of Texas at Austin, College of Pharmacy, Austin, TX, USA, 2University of Texas Southwestern Medical Center, Dallas, TX, USA

PHS115
C16
WITHDRAWN

PHS116
C17
WITHDRAWN

PHS117
C18
INCREMENTAL EFFECT OF QUALITY BLUE PRACTICES ON DISEASE MANAGEMENT IN LOUISIANA
Yuan X, Guh S, Hochheiser D, Mayo T, Nigam S
Blue Cross Blue Shield of Louisiana, Baton Rouge, LA, USA

PHS118
C19
QUALITY ASSURANCE METRICS FOR PROSTATE CANCER TREATMENT PLANS IN THE PRIVATE HEALTHCARE ENVIRONMENT
Kotze L, Izzett MD
Isimo Health, Bellville, South Africa

PHS119
C20
HEALTH CARE COST IN THE LAST YEAR OF LIFE IN PEOPLE WITH A PRIVATE HEALTH POLICY FROM COLOMBIA
Posada KM1, Ortiz AM1, Toro JM2, Trejos P1
1Suramericana de Seguros, Medellin, Colombia, 2University of Antioquia, Medellin, Colombia

PHS120
C21
IMPACT OF HUMAN PAPILLOMAVIRUS (HPV) ETIOLOGY AND IMMUNO-ONCOLOGY THERAPY (IO) AVAILABILITY ON THE PATIENT JOURNEY IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
Korytowsky B1, Radtchenko J2, Abraham P1, Klinefelter P2, Shaw JW1, Feinberg B2
1Bristol-Myers Squibb, Lawrenceville, NJ, USA, 2Cardinal Health, Dublin, OH, USA

PHS121
C22
ARE MOTHER’S BEHAVIOR, HEALTH STATUS, AND BIRTH EXPERIENCE ASSOCIATED WITH LOW BIRTH WEIGHT IN SOUTH CAROLINA? EVIDENCE FROM PRAMS, 2004-2013.
Siddiqi KA, Haider MR, Demir I, Khan MM
University of South Carolina, Columbia, SC, USA

PHS122
C23
MEDICATION SYNCHRONIZATION IMPROVES MEDICATION ADHERENCE
Mu Y, Lou Y, Rozenbaum A, Taitel MS
Walgreen Co., Deerfield, IL, USA

PHS123
C24
A TIME-MOTION OBSERVATIONAL STUDY OF CLINIC STAFF: ADMINISTRATION OF PEGFILGRASTIM PRIMARY PROPHYLAXIS VIA NEXT-DAY MANUAL INJECTION AND ON-BODY INJECTOR (OBI)
Hatfield MD1, Reitan S2, Moser L3, Chandler D1, Reiner M1, Reitan J2, Bensink M1
1Amgen Inc, Thousand Oaks, CA, USA, 2RJM Group, LLC, Crown Point, IN, USA, 3South Carolina Oncology Associates, Columbia, SC, USA

PHS124
C25
HOW VALUES INFORM THE HEALTH POLICY DECISION-MAKING PROCESSES ABOUT HEALTH-SYSTEM FINANCING IN LATIN AMERICA? A CRITICAL INTERPRETIVE SYNTHESIS
Velez CM1, Wilson MG1, Abelson J2, Lavis JN2, Florez ID1
1University of Antioquia, Medellin, Colombia, 2McMaster University, Hamilton, ON, Canada

PHS125
C26
PATIENT PREFERENCES FOR SOCIAL INCENTIVES FOR MEDICATION ADHERENCE: A DISCRETE CHOICE EXPERIMENT
Hohmann NS, Hastings TJ, Jeminiwa RN, Qian J, Hansen RA, Garza KB
Auburn University Harrison School of Pharmacy, Auburn, AL, USA

PHS126
C27
PATTERNS OF HEALTH SERVICE UTILIZATION AMONG PATIENTS UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION — A PERSON-CENTERED APPROACH
Zhou J, Han J, Nutescu EA, Calip GS
University of Illinois at Chicago, Chicago, IL, USA

PHS127
C28
INTERSEIZURE INTERVAL IN FREQUENTLY ADMITTED EPILEPSY PATIENTS
Huang Y1, Pan L1, Fishman J2, Kvedar J3, Jethwani K3, Agboola S3
1Boston University School of Public Health, Boston, MA, USA, 2UCB, Smyrna, GA, USA, 3Partners Connected Health, Boston, MA, USA

PHS128
C29
WITHDRAWN

PHS129
C30
RISK BASED CHARACTERIZATION APPLIED TO A VOLUNTARY INSURER IN COLOMBIA
Romero Prada ME1, Romero Y1, Celis S1, Lancheros J1, Villegas J2, Estrada P2
1Fundación Salutia, Bogotá, Colombia, 2Coomeva Medicina Prepagada, Cali, Colombia

PHS130
C31
WITHDRAWN

PHS131
C32
WITHDRAWN

PHS132
C33
SOCIODEMOGRAPHIC DISPARITIES IN HEALTH-RELATED QUALITY OF LIFE WITHIN A SAFETY NET PRIMARY CARE SETTING AND THE CLINICAL IMPLICATIONS OF SYMPTOM MANAGEMENT
Wirth LS
Saint Louis University Center for Health Outcomes Research (SLUCOR), Saint Louis, MO, USA

PHS133
C34
WITHDRAWN

PHS134
C35
A MEASURE OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) ASSOCIATED WITH CHRONIC CONDITIONS USING EQ-5D-5L IN HONG KONG SAR,CHINA
Xu RH1, Cheung AW2, Wong EL2
1The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2Chinese University of Hong Kong, Hong Kong, Hong Kong

PHS135
C36
PATIENT SATISFACTION, ADHERENCE , COMPLIANCE , PERSISTENCE IN HEALTHCARE . PRELIMINARY REAL-WORLD EVIDENCE (RWE) IN A PRIVATE HEALTH INSURANCE IN LATIN AMERICA COUNTRY .
Bregola E1, Zimmer L1, Lakoski J1, Lima C1, Bazzo D1, Machado C1, Tanaka GK2, Tanaka F1, Brégola V1, Tanaka E1
1COPEL FOUNDATION, CURITIBA, Brazil, 2MEDICAL COLLEGE PEQUENO PRINCIPE UNIVERSITY, CURITIBA, Brazil

PHS136
C37
WITHDRAWN

PHS137
C38
DETERMINANTS OF ASTHMA IN CHILDREN: EVIDENCE FROM NATIONAL SURVEY OF CHILDREN’S HEALTH IN USA
Sriram S, Khan MM
University of South Carolina, Columbia, SC, USA

PHS138
C39
THE EFFECTIVENESS OF INTEGRATED TREATMENT OF GENERALIZED PERIODONTITIS FOR PATIENTS WITH CHRONIC HEPATITIS C
Blavatska O, Minko L, Slaba O, Sichkoriz K
Danylo Galytskyi Lviv national medical university, Lviv, Ukraine

PHS139
C40
PRACTICAL IMPLICATIONS OF FLEXIBLE WORK ARRANGEMENTS – A SURVEY OF SELECTED PHARMACEUTICAL/HEALTHCARE ORGANIZATIONS
Gurjar K1, Mathew MP2, Sharma A3
1NIPER, Ahmedabad, Gujarat, India, 2National institute of Pharmaceutical education and research, Mumbai, India, 3NIPER, Mohali, India

PHS140
C41
DIFFERENCES IN RISKS OF SYNCHRONOUS AND METACHRONOUS SECOND PRIMARY CANCERS AMONG HEAD AND NECK CANCER PATIENTS
Adjei Boakye E1, Buchanan PM1, Hinyard L1, Osazuwa-Peters N2, Simpson M3, Burroughs TE4
1Saint Louis University Center for Health Outcomes Research (SLUCOR), Saint Louis, MO, USA, 2Saint Louis University Cancer Center, Saint Louis, MO, USA, 3Saint Louis University School of Medicine, Saint Louis, MO, USA, 4Saint Louis University Center for Outcomes Research (SLUCOR), Saint Louis, MO, USA

PHS141
C42
STUDY OF PREVALENCE OF TOBACCO USE AMONG CHILDREN AND YOUTH IN INDIA
Sriram S1, Noochpoung R2
1University of South Carolina, Columbia, SC, USA, 2University of South Carolina, COLUMBIA, SC, USA

PHS142
C43
WITHDRAWN

PHS143
WITHDRAWN

PHS144
C44
WITHDRAWN

PHS145
C45
WITHDRAWN

PHS146
C46
A COMPARISON OF T2DM PATIENT CHARACTERISTICS IN 2009-2012 VS. 2013-2016 USING DATA FROM THE MALAYSIAN NATIONAL DIABETES REGISTRY
Azmi S
Azmi Burhani Consulting, Petaling Jaya, Malaysia

PHS147
D1
LONG-TERM BENEFITS OF EMPLOYEE WELLNESS PROGRAMS: A BLUE CROSS BLUE SHIELD OF LOUISIANA (BCBSLA) CASE STUDY
Williams H, Guh S, Barrack A, Boss K, Nigam S
Blue Cross Blue Shield of Louisiana, Baton Rouge, LA, USA

PHS148
D2
READINESS OF COMMUNITY ONCOLOGY AND UROLOGY PRACTICES FOR VALUE-BASED CARE
Verma-Kurvari S, Garofalo D, Montgomery J, Xu B, Scott J
Integra Connect, West Palm Beach, FL, USA

PHS149
D3
WITHDRAWN

PHS150
D4
WITHDRAWN

PHS151
D5
IMPACT OF AFFORDABLE CARE ACT ON MEDICARE DISPROPORTIONATE SHARE HOSPITAL (DSH) PAYMENTS
Haider MR, Siddiqi KA, Demir I, Khan MM
University of South Carolina, Columbia, SC, USA

PHS152
D6
THE IMPACT OF FUNCTIONAL STATUS AND MULTI-MORBIDITY ON SURVEILLANCE USE AMONG MEDICARE BENEFICIARIES WITH BLADDER CANCER
Georgieva M1, Lund JL1, Nielsen ME2, Trogdon J1, Dinan MA3, Weinberger M1, Wheeler SB1
1Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 2UNC School of Medicine, Chapel Hill, NC, USA, 3Duke Clinical Research Institute, Durham, NC, USA

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.